| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,773 |
11,675 |
$1.42M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,003 |
1,975 |
$243K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
606 |
603 |
$75K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
438 |
438 |
$54K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
304 |
304 |
$38K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,541 |
2,519 |
$26K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
182 |
181 |
$9K |
| 99051 |
|
2,677 |
2,662 |
$5K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
33 |
33 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
100 |
99 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
76 |
76 |
$679.00 |
| 81003 |
|
271 |
268 |
$538.84 |
| 81025 |
|
175 |
175 |
$350.00 |
| 93000 |
|
13 |
13 |
$195.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
64 |
63 |
$8.54 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
30 |
30 |
$6.12 |
| 99072 |
|
1,672 |
1,646 |
$0.00 |